TCT 2022 Late-Breaking Science Collection
Published: 08 September 2022
-
Views:
2202 -
Likes:
7
-
Views:
2202 -
Likes:
7
-
Up Next
-
27m 14sPart 1 | Session 2 TCT 22 Late-breaking Science Preview
-
6m 5sPart 2 | Session 1 PROTECTED-TAVR: Sentinel® Stroke Protection System During TAVR
-
5m 12sPart 2 | Session 2 RADIANCE II: Paradise Renal Denervation in Pts With Hypertension
-
9m 21s
-
6m 38s
-
7m 21sPart 2 | Session 5 FAME 3: FFR-Guided PCI Vs CABG in Pts With Multivessel CAD
-
6m 9s
-
5m 35s
-
6m 36s
-
4m 10sPart 2 | Session 9 FLASH Trial: US Outcomes of the FlowTriever for Pulmonary Embolism
Overview
Stay up-to-date with our regular review series, View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this #TCT2022 edition they provide a short analysis of the most pertinent data from 15 late-breaking science presentations.
Short, accessible Expert Interviews were conducted with investigators focusing on study design, key results and applicability of the latest data.
More from this programme
Part 1
View from the Thoraxcenter
Part 2
Expert Interviews
Faculty Biographies
Nicolas M Van Mieghem
Medical Director
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.